GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment

$380,000
Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2022 · OD

Cell Control via Spatiotemporal Microenvironmental pH Modulation

$379,990
Jinglei Ping · University Of Massachusetts Amherst · R35 · FY2024 · GM

Exploiting gold nanoparticle as a probe to identify therapeutic targets

$379,984
Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA

Local Administration of Particle-Anchored Cytokines as a Safe and Effective Cancer Immunotherapy

$379,981
Rong Tong · Virginia Polytechnic Inst And St Univ · R21 · FY2024 · CA

Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation

$379,977
Yingzi Yang · Harvard Medical School · R01 · FY2022 · CA

Investigating T Cell Egress via Lymphatic Vessels in Melanoma

$379,977
Amanda W. Lund · New York University School Of Medicine · R01 · FY2023 · CA

Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination

$379,977
Joshua D Brody · Icahn School Of Medicine At Mount Sinai · R37 · FY2023 · CA

Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression

$379,977
Kwok Kin Wong · New York University School Of Medicine · R01 · FY2022 · CA

New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors

$379,970
Ann Richmond · Vanderbilt University · R01 · FY2021 · CA

Initiation and evolution of the ovarian cancer microenvironment

$379,960
Jose R Conejo-Garcia · Wistar Institute · R01 · FY2015 · CA

Novel Strategies for Pancreatic Cancer Treatment

$379,899
Jennifer D Black · University Of Nebraska Medical Center · P50 · FY2017 · CA

Tumor cell and microenvironment changes causing antiangiogenic therapy resistance

$379,887
Manish Aghi · University Of California, San Francisco · R01 · FY2019 · NS

Microfluidic platform for tumor cell invasion

$379,858
Mingming Wu · Cornell University · R01 · FY2017 · CA

Nanotechnology Platforms for the Prevention and Personalized Therapy of Pancreati

$379,826
Craig D Logsdon · University Of Texas Hlth Sci Ctr Houston · U54 · FY2012 · CA

Transcriptional effects and non-transcriptional effects of estrogen in the pathogenesis of Inflammatory Breast Cancer

$379,825
Esther A Peterson · University Of Puerto Rico Rio Piedras · R21 · FY2020 · CA

Endocrine disruption of myometrial stem cell activities

$379,787
Jose M Teixeira · Michigan State University · R01 · FY2014 · OD

Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme

$379,771
Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA

MicroRNA regulation of RasGAP's during angiogenesis

$379,750
David A Cheresh · University Of California, San Diego · R01 · FY2014 · HL

Ovarian Cancer Chemoprevention

$379,695
Doris Mangiaracina Benbrook · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · CA

Regulation of Caspase-1 Signaling and Inflammation by the P2X7 ATP Receptor

$379,694
George R Dubyak · Case Western Reserve University · R01 · FY2012 · GM

Regulation of Caspase-1 Signaling and Inflammation by the P2X7 ATP Receptor

$379,694
George R Dubyak · Case Western Reserve University · R01 · FY2011 · GM

Regulation of Caspase-1 Signaling and Inflammation by the P2X7 ATP Receptor

$379,694
George R Dubyak · Case Western Reserve University · R01 · FY2014 · GM

Delineating how nucleic acid sensing in tumorcells regulate anti-tumor immune responses

$379,690
Malay Haldar · University Of Pennsylvania · P01 · FY2025 · CA

IDO2 Targeting in Pancreatic Cancer

$379,675
George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2019 · CA

Measuring extracellular pH in pre-clinical tumor models with CEST MRI

$379,673
Mark David Pagel · University Of Arizona · R01 · FY2014 · CA